chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial information received on 15-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves a 78 years old female patient who experienced terrible tingling- All over body and joint pain, while she received vaccine FLUZONE HIGH DOSE. The patient's past medical history included Paraesthesia. The patient's past vaccination(s) included FLUZONE HIGH DOSE. The patient's past medical treatment(s) and family history were not provided. On 02-Oct-2018, the patient received a 0.5 mL dose of suspect Influenza USP Trival A-B High Dose Subvirion Vaccine lot number not reported (expiry date, route and site of administration were not reported). On an unknown date, the patient developed a non-serious terrible tingling- All over body (paraesthesia) and joint pain (arthralgia) following the administration of Influenza USP Trival A-B High Dose Subvirion Vaccine. Other relevant tests included No lab data. Final diagnosis was joint pain and terrible tingling- all over body. It was not reported if the patient received a corrective treatment. The outcome of the events not reported. Additional information downloaded from Regulatory Authority database (level 2B) was received from consumer on 15-Oct-2018. Patient's past medical history updated. Additional information downloaded from Regulatory Authority database (level 2B) was received from consumer on 15-Oct-2018. No new information received. List of documents held by sender- none.
pruritus all over her body; This is a spontaneous report from a contactable consumer (patient).  A 54-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Batch/Lot number: Unknown), dose 1 via an unspecified route of administration on 24Feb2021 as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On Mar2021, patient experienced pruritus all over her body. The clinical course was reported as follows: The patient received the first dose of the Pfizer Covid vaccine on 24Feb2021. On Mar2021, (reported as week ago) she started feeling pruritus all over her body. She did not care much about it since she did not have any rash but she cannot resist the urge to scratch herself. She has an appointment to get the second dose on 16Mar2021 and she asked if she should get to the appointment and get the vaccine. The outcome for pruritus all over her body was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Quadrantanopia in his right eye and was diagnosed with an Acute Occipital Stroke.; Information has been received from a lawyer, regarding a case in litigation referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant therapies was not provided.     On or around 02-DEC-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, route, dose, lot # and expiration were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Subsequently, on an unknown date, the patient experienced quadrantanopia in his right eye and was diagnosed with an acute occipital stroke (cerebrovascular accident). As a direct and proximate result of vaccination with zoster vaccine live (ZOSTAVAX), the patient's symptoms resulted in physical limitations not present prior to vaccination. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. Furthermore, the patient sustained severe and permanent personal injuries, also suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of defendants' conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  At the time of reporting, the outcome of cerebrovascular accident was determined as not recovered. The reporter considered cerebrovascular accident to be related to Zoster Vaccine Live(ZOSTAVAX).     Upon internal review, cerebrovascular accident was determined to be serious due to disability and a medically significant event.
Vaccine at approx 8:18am.  2-5mins later felt intense burning below injection site which radiated down into wrist within 1hr of vaccination.   2:45pm- extreme fatigue and unable to lift left arm more than 2 inches due to pain.   4:30pm - (in addition to the above symptoms) Low grade fever (99.3-99.8) body aches, nausea.   7:15pm- headache, fever increase to 100.5   3:00am - woken by severe headache and extreme body/muscle/joint pain. Painful to walk. Fever of 101.3. Chills. Unable to sleep.
Fever Body aches Headache Trouble sleeping Chills Joint pain All lasted around 24hrs
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 62-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had a headache (after the first dose, experienced adverse events; nothing life-threatening or anything), felt abnormal (brain fog), dizziness and arthralgia (maybe a little joint pain), with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Fatigue, chills, nausea - The fatigue and nausea lasted off and on for 9 days
CLIENT C/O BEING COLD, DIZZY, THEN MOUTH, ARMS, AND HANDS STARTING TWITCHING, ALONG WITH BIG TOE. AMBULANCE CALLED.  EYES GLAZED OVER AND DILATED AND FIXXED.  THEN UNRESPONSIVE. AMBULANCE FROM FAYETTE COUNTY HOSPITAL IN VANDALIA, IL CALLED AND CLIENT TAKEN TO ER.  5/8/09 ED records received DOS 5/5/09. FINAL DIAGNOSIS: Drug reaction Nauseated, dizzy, twitching. 'Things got dark', could not hear people. Jerky movements, lethargic. Impaired airway. Shortness of breath, tachycardia. Condition improved while in ED and discharged.
patient recieved dose #2 outside of the recommended age group. No reaction or adverse event related to the vaccine administered.
1st Moderna vaccine 4/10/2021, 2nd was 5/8/2021.  Headaches started between 5/1 and 5/4/2021.  patient thinks the headaches were triggered by the vaccine. they started about 2-3 weeks after the 1st dose.  o Onset 10-14 days ago. Entire right side of head. Mostly parietal/occipital.  Hurts more when eyes look to the LEFT.   o 1 tab of Advil resolved pain x 18 hours.  Hasn't had a headache for 3 days now.  o Has an associated (but not always present) eye strain. Sometimes has more eye strain than headache.   o Hasn't noted a correlation between computer work and headaches. o Doesn't wake up with the headaches.  No pattern to headaches.  No noted phonophobia or photophobia.  No associated nausea.  No aura symptoms.  Improved after husband massaged her neck.  o No history of significant motion sickness.  after 2 months the headaches resolved on their own.
1/9: COVID Omicron booster on LA, flu vaccine on RA.  1/10: SOB, chest tightness to present, seems positional, sharp pain over precordium. Has used albuterol in the past. Felt stiff/sore in arms attributed to immunization. Positional, worse with leaning forward but not consistently reproducible, and with R arm internally rotated and crossed on chest.  Slight decrease in exercise tolerance starting 1/10 notes intermittent SOB.  COVID 10/2020, minimal symptoms x 24h.  Seen 1/11. VSS, EKG mild tachycardia (103) not present when rechecked. Flu/COVID neg antigen test.  Albuterol Rx and f/u Cardiology.
Staph infection from Abscess from shot. Subcutaneous pheomycotic abscess and cystsSubcutaneous pheomycotic abscess and cyst
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. Since July 2014 the patients were vaccinated with a dose of improperly stored VAQTA (dose, route of administration and lot # were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Grey dots on legs; This case was reported by a pharmacist and described the occurrence of skin discoloration in a patient who received DTPa-HBV-IPV (Pediarix) (batch number X9HS4, expiry date unknown) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, Hib (Hiberix) (batch number EK5Y2, expiry date unknown) for prophylaxis and PNEUMOCOCCAL VACCINE (PREVENAR) for prophylaxis.   On 8th June 2022, the patient received the 1st dose of Pediarix, Pediarix Pre-Filled Syringe Device and the 1st dose of Hiberix. On an unknown date, the patient received PREVENAR. On an unknown date, less than 3 months after receiving Pediarix, Pediarix Pre-Filled Syringe Device and Hiberix, the patient experienced skin discoloration. On an unknown date, the outcome of the skin discoloration was unknown.   It was unknown if the reporter considered the skin discoloration to be related to Pediarix, Pediarix Pre-Filled Syringe Device and Hiberix.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2022AMR171039, US2022AMR171042   Additional Information: GSK Receipt Date: 16-NOV-2022 Reporter's Comments:  The patient experienced the gray dots that have been noted on patient's legs after receiving Pediarix in the right thigh and Hiberix. The reporter consented to follow up. Additional supportive information: It was unknown if the reporter considered the skin discoloration to be related to Prevenar, For tolerance to the 2nd and 3rd dose refer case US2022AMR171039 and US2022AMR171042. This was 1 of 19 linked cases, reported by same reporter.; Sender's Comments:  US-GSK-US2022AMR171025:Same reporter US-GSK-US2022AMR171007:Same reporter US-GSK-US2022AMR171025:Same reporter US-GSK-US2022AMR171028:Same reporter US-GSK-US2022AMR148962:Same reporter US-GSK-US2022AMR149551:Same reporter US-GSK-US2022AMR171047:Same reporter US-GSK-US2022AMR171007:Same reporter US-GSK-US2022AMR149560:Same reporter US-GSK-US2022AMR148961:Same reporter US-GSK-US2022AMR149561:Same reporter US-GSK-US2022AMR148919:Same reporter US-GSK-US2022AMR171039:Same reporter US-GSK-US2022AMR171042:Same reporter US-GSK-US2022AMR171044:Same reporter US-GSK-US2022AMR171048:Same reporter US-GSK-US2022AMR171050:Same reporter US-GSK-US2022AMR171052:Same reporter US-GSK-US2022AMR171056:Same reporter US-GSK-US2022AMR171062:Same reporter
flu; Initial information received from United States on 14-Feb-2022 regarding an unsolicited valid social media non-serious case received from a consumer.  This case involves Adult and unknown gender patient who experienced flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date in Oct ( year unspecified) , the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer with unknown strength, lot number and expiration date via unknown route in unknown administration site for immunization. There will be no information available on the batch number for this case.  On an unknown date in January (year unspecified) the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
The left side of my face went numb. The left side of my mouth was droopy from the numbness and I became hard to swallow.
10cm x 5cm area of erythema, swelling, induration @ inj site w/in 24hrs of inj;treated w/ATB (Duricef) x 10 days for cellulitis;
Patient stated he broke out in "chicken pox", 19 days after having the Shingrix vaccine.  Had fluid filled blisters that popped and became crusted over.  lesions were very itchy.
SLIGHT DIZZINESS, THEN FAINTED, UNCONCIOUS FOR A FEW MINUTES, MOTHER ASKED US TO CALL 911 - REGAINED CONSCIOUSNESS AFTER 3-4 MINUTES, PALE BUT AFTER IS FINE,
After vaccine was administered , pt. reported facial numbness, headache,  nauseas,  Pt. was assessed by pcp and vital signs were taken every 15 minutes, Pt. was sent home with ER precautions An appointment was given for next day for reassessment
GOUT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAY-2021 for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced gout. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of gout was not reported. This report was non-serious.
Received hepatitis B vaccine Saturday evening 3-17-07 at approximately 6:30pm. Between 9:00 and 9:30p started having heart palpitation Sunday morning at approximately 7:00 am blurred vision, fainted. Transported to medical center - lab work, chest x-ray and EKG obtained - some PVCS noted (did not admit). Syncope episode around 1:30pm 3-19-07.
Pt was given an adult dose of Hep A instead of the adolescent version. There has been reeducation for the staff to triple checking vaccines to keep this from occurring again. Pt will still received the 2nd dose of Hep A in 6 months to finish out series. This pt is 186# and 70". Age of patient at time of event: 15 years 8 months.
Arm soreness/Tingling sensation also felt in fingers, as well as the sharper soreness; Soreness around site of injection; Tingling sensation also felt in fingers; Soreness also encompassed shoulder and left section of my chest; This is a spontaneous report from a contactable consumer. A 26-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 14:00, (at the age of 26-year-old), as 1st dose, single for COVID-19 immunization. Medical history included electrocardiogram qt prolonged, covid-19, food allergy (Some fruits (mainly skins on apples, kiwis, carrots, celery, etc.) But nothing severe). Concomitant medications included Nadolol (20mg, 3x daily). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not have covid prior vaccination and no covid tested post vaccination. On Apr2021, the patient experienced arm soreness/tingling sensation also felt in fingers, as well as the sharper soreness, soreness around site of injection, tingling sensation also felt in fingers, soreness also encompassed shoulder and left section of my chest. This lasted 7 days after the first dose, then it was gone. The outcome of the events pain in extremity, vaccination site pain and paresthesia was recovered on an unspecified date in Apr2021 (7 days after vaccination). And outcome of event arthralgia was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
3/7/2021 approximately 11:00 p.m. Swollen lymph node under left arm with pain. Treatment: applied Neosporin and doctor prescribed amoxicillin-clavulanate 875-125 x2 for 10 days. 3/16/2021 Red itchy rash on left arm at point of injection. Area got smaller over several days.  Treatment:  warm compress and applied hydrocortisone.  Finally went away after 5-7 days.
moderate intensity myalgias and arthralgias; moderate intensity myalgias and arthralgias; fatigue; headache; This is a spontaneous report from a contactable physician. A 41-year-old female patient received the first does of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EH9899), via an unspecified route of administration on the left arm on 16Dec2020 09:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included rhinitis allergic from an unknown date and unknown if ongoing, eczema from an unknown date and unknown if ongoing. Concomitant medication included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and ethinylestradiol, norgestimate (TRINESSA). The patient previously took septra and experienced drug hypersensitivity. After the first dose of the COVID 19 vaccine, on 16Dec2020 20:00 the patient developed moderate intensity myalgias and arthralgias, also significant fatigue and headache. She waited the 2-3 days after vaccination to see if adverse reaction improved and for the first dose it improved at the third day but unfortunately the same symptoms started again one week after second dose of vaccine and have no improved. No treatment was received for the events. The outcome of the event was not recovered.
Chills, muscle aches, joint pain Aleve OTC, mild relief 15 hrs, still feeling like I have the flu
after administering pts 2nd moderna covid vaccine, pt was instructed to wait for 15 minutes in the waiting area. While the pt was waiting he signaled me over and indicated that he felt as if he was about to have a seizure. As I was calling EMS a technician stayed with the pt. He had 2 seizing episodes while seated in the waiting area until EMS arrived. Pt then left with EMS on stretcher
Information has been received from a physician concerning a female who was vaccinated with GARDASIL. Subsequently the patient experienced "knot at the injection site where the GARDASIL was given". It was unknown if the patient sought medical attention. The patient was recovered at the time of report. Additional information has been requested.
flu shot made patient sick 20 minutes after he/ she got it, was throwing up; Initial information received on 02-Dec-2021 regarding an unsolicited valid non-serious social media case received from a consumer via social media via Digital Media.  This case involves an unknown age and gender patient who was sick for 20 minutes and was throwing up (vomiting), after receiving INFLUENZA VACCINE.  The patient's past medical treatments, vaccinations, concomitant medications and family history were not provided.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date in 2020, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiry date not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced a non-serious event "flu shot made patient sick 20 minutes after he/ she got it, was throwing up" (vomiting) following the administration of INFLUENZA VACCINE.  It was reported "Last year the flu shot made me sick 20 minutes after I got it was throwing up. Was sick for over two weeks."  It is unknown if the patient experienced any additional symptoms/ events.   It is unknown if there were laboratory data/ results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome of the event was reported as unknown.  There will be no information on the lot number for this case.
Sore arm at injection site; cold sore; Sore throat; This is a spontaneous report from a non-contactable Pharmacist(patient). The 26-year-old male patient received first dose BNT162B2(Covid 19, lot EK5730), via an unspecified route of administration at left arm on 28Dec2020 17:15 at single dose for COVID-19 immunization in hospital.  Medical history included last cold sore was over 2 years ago. There was no other vaccine in four weeks. There was no known allergies, no other medical history.  There were no concomitant medications.  The patient experienced sore throat occurred 2 days after vaccination(30Dec2020), sore arm at injection site, cold sore appearance 8 days after vaccination, both on 05Jan2021. There was no treatment. There was no covid prior vaccination, covid tested post vaccination was Nasal Swab with PCR on 08Jan2021 with negative result.  Outcome of events was recovered in Jan2021 .   No follow-up attempts are possible. No further information is expected.
Localized itchy lump and swelling at injection site lasting for 3 days. Approx 3" wide and 4" long. Reports generalized itchiness on trunk of body and extremities lasting x 1 wk. No raised welts or hives. Nov 5 developed bumps at injection site very itchy.
At around 6:45PM in November 12th, pt became very lethargic and said he couldn?t eat his dinner (we had made his favorite meal). He did not eat and at about 8:00pm he aggressively vomited for about 4 minutes. Vomiting episodes continued every 90 minutes to two hours until 10:00am the next morning, despite largely being dry heaves and bile toward the end. Patient also had a fever up to 101.7. At 10:15 we attended a medical appointment with pt primary care provider who gave him Zofran to treat the nausea, which help significantly.   Patient only drank small amounts of liquids on November 13th and rested. He slept for approximately 15 hours from 13-14 November. We woke him to check on him and proved him fluids.
LIGHT HEADED, BLURRY VISION STARTED RIGHT AFTER ADMINISTRATION, PERSISTS AFTER 4 DAYS
Pt recvd vax 28OCT92 & 30OCT92 pt devel intermittent itching @ the shoulder & hamstring areas; also exp nausea & 3 days following vax devel vomiting;
I started with a very itchy scalp as I was driving to the office after my shot. Shot was at 9:45, I arrived at the office around 10:23 and felt very itchy. I took two Tylenol when I arrived as advices for soreness. I felt hives/rash on the back of my neck around 12:15 or so. Then in my underarm, back of my knee and inner elbow area. I started feel nausea. I drank plenty of water and had a few bites to eat. My hives/rash were popping up and I was using topical Benadryl. Soon after, I took on 25 mg Benadryl. I called my doctor?s office for guidance around 4: 10 pm and then started throwing up. I had someone drive me home. No fever.  I developed red hives around my hairline and around eyes. Felt very tired.                                      Next day, I stayed off work and drank plenty of water and slept a lot. Rash had cleared but the red hives around my hair line and eyes were visible. Called doctors office and was told to continue Benadryl.
This spontaneous report as received from a pharmacy student refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (dose, lot #, route of administration were not reported). The vaccine was stored for 72 hours at the temperature of 27 degrees Fahrenheit. No adverse effects were reported. Additional information is not expected as there is no consent to contact the reporter.
Swelling of the under arm midaxillary location (arm pit) of the left arm.  Pain with the swelling. High fever and body chills for less than 12 hours.  Swelling and discomfort at the midaxillary point is still on-going over 24 hours.